Open AccessSorafenib treatment of metastatic melanoma with c‑Kit aberration reduces tumor growth and promotes survival
Author(s) -
Tomoya Takeda,
Masanobu Tsubaki,
Natsuki Kato,
Shuji Genno,
Eri Ichimura,
Aya Enomoto,
Motohiro Imano,
Takao Satou,
Shozo Nishida
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.13089
Subject(s) - sorafenib , cancer research , melanoma , in vivo , metastasis , medicine , oncogene , tyrosine kinase inhibitor , viability assay , platelet derived growth factor receptor , cell cycle , cell , cancer , biology , growth factor , receptor , hepatocellular carcinoma , genetics , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom